Regulatory in brief | nitrosamines, vitamin D
10 July 2020
Europe takes more action to reduce nitrosamines in medicines, while the UK offers advice on vitamin D and COVID-19.
Industry News
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
German change highlights Stada’s consumer ambitions
8 July 2020
Stada has changed the name of its German consumer healthcare business in a move that highlights the company’s ambitions.
Shop Apotheke Europe records 42% sales growth
Premium
7 July 2020
Shop Apotheke Europe said sales in the second quarter of 2020 were up by 42% as it attracted 0.5 million new active customers amid the COVID-19 pandemic.
Sibbing leads new consultancy TentaConsult
7 July 2020
Tentamus Group has launched a healthcare consulting company led by Ralf Sibbing, former general manager of Diapharm.
Products in brief | Beiersdorf, Gerber, Infirst
7 July 2020
Beiersdorf is eliminating packaging leaflets for Eucerin, Gerber has launched gummy multivitamins, and Infirst Healthcare has a new UK television advertising campaign for Flarin.
Galenica boosts Verfora with Hedoga acquisition
Premium
6 July 2020
Galenica has boosted its Verfora consumer healthcare business by acquiring Swiss company Hedoga Group – including its Osa, Osanit and Carmol brands – for an undisclosed sum.
RB hires P&G’s Kuhn for transformation role
6 July 2020
Reckitt Benckiser (RB) has recruited Procter & Gamble’s (P&G’s) Volker Kuhn as chief transformation officer with effect from 1 August 2020. He will be a member of RB’s global executive committee.
Angelini Pharma hires new head for Italy
Premium
3 July 2020
Angelini Pharma has appointed Rosita Calabrese as country manager for Italy, replacing Fabio De Luca who has taken on the new role of global marketing pharma.
Midsona buys Gainomax sports-nutrition brand
Premium
1 July 2020
Midsona has strengthened its position in sports nutrition by acquiring the Gainomax brand from Swedish dairy company Norrmejerier for SEK60 million (USD6.5 million).
Carlyle to take 20% stake in Piramal Pharma
Premium
1 July 2020
Private-equity firm The Carlyle Group is taking a 20% stake in Piramal Pharma, which houses Piramal’s Consumer Products division, for around USD490 million. The investment will be used to “accelerate” Piramal Pharma’s organic and inorganic growth plans.